ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 83 filers reported holding ZAI LAB LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $2,186,400 | +12.4% | 80,000 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $1,944,800 | +0.2% | 80,000 | +14.3% | 0.00% | 0.0% |
Q2 2023 | $1,941,100 | +48102.1% | 70,000 | -42.2% | 0.00% | 0.0% |
Q1 2023 | $4,027 | -2.3% | 121,080 | -9.8% | 0.00% | -50.0% |
Q4 2022 | $4,122 | -99.9% | 134,280 | -5.1% | 0.00% | 0.0% |
Q3 2022 | $4,838,000 | +6.7% | 141,480 | +8.2% | 0.00% | 0.0% |
Q2 2022 | $4,536,000 | -12.3% | 130,780 | +11.2% | 0.00% | 0.0% |
Q1 2022 | $5,171,000 | -50.6% | 117,580 | -29.5% | 0.00% | -33.3% |
Q4 2021 | $10,476,000 | -35.4% | 166,680 | +8.4% | 0.00% | -40.0% |
Q3 2021 | $16,207,000 | -28.4% | 153,780 | +20.2% | 0.01% | -28.6% |
Q2 2021 | $22,651,000 | +42.7% | 127,980 | +7.6% | 0.01% | +40.0% |
Q1 2021 | $15,871,000 | -20.4% | 118,950 | -19.2% | 0.01% | -28.6% |
Q4 2020 | $19,929,000 | +101.2% | 147,250 | +23.6% | 0.01% | +75.0% |
Q3 2020 | $9,905,000 | +60.0% | 119,100 | +58.1% | 0.00% | +33.3% |
Q2 2020 | $6,189,000 | +90.5% | 75,349 | +19.4% | 0.00% | +50.0% |
Q1 2020 | $3,248,000 | +473.9% | 63,100 | +260.6% | 0.00% | – |
Q3 2019 | $566,000 | -3.9% | 17,500 | +3.6% | 0.00% | – |
Q2 2019 | $589,000 | – | 16,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zeal Asset Management Ltd | 106,171 | $2,938 | 14.16% |
Genesis Investment Management, LLP | 1,352,222 | $37,420,559 | 4.06% |
Segantii Capital Management Ltd | 1,795,479 | $49,788,633 | 2.59% |
HSG Holding Ltd | 694,634 | $19,262,201 | 2.20% |
Paradigm Biocapital Advisors LP | 865,297 | $23,994,686 | 1.85% |
INDUS CAPITAL PARTNERS, LLC | 25,256 | $700,349 | 1.41% |
Privium Fund Management B.V. | 240,683 | $6,366,065 | 1.34% |
Vivo Capital, LLC | 445,505 | $12,353,854 | 0.85% |
Rock Springs Capital Management LP | 1,222,423 | $33,897,790 | 0.81% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $2,189,505 | 0.67% |